Chandan Healthcare Limited (NSE:CHANDAN)

India · Delayed Price · Currency is INR

218.60

-10.40 (-4.54%)

At close: Oct 23, 2026

Market Cap	5.35B -32.3%
Revenue (ttm)	2.94B +20.4%
Net Income	287.65M +27.1%
EPS	11.03 +5.7%
Shares Out	24.45M
PE Ratio	19.83
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	36,000
Open	234.95
Previous Close	229.00
Day's Range	213.75 - 235.00
52-Week Range	185.40 - 358.00
Beta	n/a
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 13, 2026

About Chandan Healthcare

Chandan Healthcare Limited operates laboratories in India. The company offers pathology services; biochemistry, hematology, histopathology, microbiology, and immunology services; radiology diagnostic services, including computed tomography (CT) scans, x-rays, ultrasound, BMD, OPG, mammography, and magnetic resonance imaging (MRI) services; blood and other laboratory investigations; and retail pharmacy services. It also provides comprehensive heart health assessments comprising electrocardiography (ECG), echocardiography, and stress tests; respi... [Read more]

Industry Medical Laboratories

Founded 1991

Employees 1,425

Stock Exchange National Stock Exchange of India

Ticker Symbol CHANDAN

Full Company Profile

Financial Performance

In fiscal year 2026, Chandan Healthcare's revenue was 2.76 billion, an increase of 20.11% compared to the previous year's 2.30 billion. Earnings were 270.57 million, an increase of 22.04%.

Financial Statements